Recent investigations into long non-coding RNAs have found that LIFR antisense RNA 1 (LIFR-AS1) is significantly under-expressed in Luminal B breast cancer, and lower levels are associated with a poorer prognosis [65]. Here, LIFR is linked to breast carcinoma.